The Northwest Participant and Clinical Interactions Network: Increasing opportunities for patients to participate in research across the Northwestern United States

Author:

Baldwin Laura-Mae,Hassell Laurie,Laukes Cindi,Doyle Michelle,Reedy Anne,Mollis Brenda,Albritton Sandra,Ciemins Elizabeth,Coker Robert,Brant Jeannine,Tuttle Katherine R.,Baker Laura,Ramsey Bonnie

Abstract

IntroductionThe Institute of Translational Health Sciences (ITHS) promotes and supports translational research collaboration between clinicians, communities, and investigators across the five-state Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region. The ITHS has developed a collaborative regional clinical research network, the Northwest Participant & Clinical Interactions Network (NW PCI), involving 12 diverse clinical health systems and academic institutions.MethodsThis descriptive article details NW PCI’s development, infrastructure and governance, tools, characteristics, and initial outcomes.ResultsRegional NW PCI sites are conducting largely industry-sponsored studies; they are interested in including more grant-funded research. Regional NW PCI sites had over 1,240 open studies involving over 6700 patients in 2016. NW PCI trials are largely industry-sponsored; NW PCI sites are interested in including more grant-funded research. In its first three years, the NW PCI Coordinating Center facilitated regional sites’ participation in 34 new grant and contract applications across diverse topics.ConclusionThe NW PCI model supports the goals of the developing CTSA Trial Innovation Network by increasing access to cutting-edge research across the Northwestern U.S., by supporting investigators seeking diverse populations, including those with rare diseases, for their research studies, and by providing settings to test implementation and dissemination of effective interventions.

Publisher

Cambridge University Press (CUP)

Subject

General Medicine

Reference23 articles.

1. National Institutes of Health, National Cancer Institute. An overview of NCI’s National Clinical Trials Network [Internet]. 2015. [cited Feb 14, 2017]. (http://www.cancer.gov/research/areas/clinicaltrials/nctn)

2. Hartwig K , Calleston D , Williams M . Unit 1, Section 1.1: Definitions, rationale and key principles in CBPR. In: The Examining Community-Institutional Partnerships for Prevention Research Group. Developing and Sustaining Community-Based Participatory Research Partnerships: A Skill-Building Curriculum [Internet]. [cited Feb 14, 2017]. 2006. (https://depts.washington.edu/ccph/cbpr/intro/intro.php)

3. US Department of Health & Human Services, National Institutes of Health. NIH Research Portfolio Online Reporting Tools (RePORT) [Internet]. 2014. [cited Feb 14, 2017]. (https://report.nih.gov/fundingfacts/fundingfacts.aspx)

4. Progress in cystic fibrosis and the CF Therapeutics Development Network

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3